Gilead Sciences (GILD) EBT Margin Growth (3y) (2012 - 2026)
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBT Margin Growth (3y) (Qtr) |
| 1 |
Novartis Ag |
107,124,802.25 Bn |
107,124,802.25 Bn |
- |
- |
| 2 |
Eli Lilly |
969.00 Bn |
963.72 Bn |
16.22 Bn |
2,272.00 |
| 3 |
Johnson & Johnson |
539.46 Bn |
517.41 Bn |
15.96 Bn |
3,105.00 |
| 4 |
AbbVie |
376.92 Bn |
367.57 Bn |
10.78 Bn |
304.00 |
| 5 |
Merck |
285.00 Bn |
279.35 Bn |
12.09 Bn |
-4,669.00 |
| 6 |
Amgen |
177.58 Bn |
165.55 Bn |
5.87 Bn |
-3,220.00 |
| 7 |
Gilead Sciences |
163.22 Bn |
155.50 Bn |
5.52 Bn |
1,660.00 |
| 8 |
Pfizer |
145.86 Bn |
133.09 Bn |
-1.21 Bn |
-3,734.00 |
| 9 |
Bristol Myers Squibb |
111.90 Bn |
101.44 Bn |
8.07 Bn |
377.00 |
| 10 |
Gsk |
88.34 Bn |
83.66 Bn |
- |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
1,660.00 |
| Dec 31, 2025 |
-127.00 |
| Sep 30, 2025 |
1,233.00 |
| Jun 30, 2025 |
1,029.00 |
| Mar 31, 2025 |
2,704.00 |
| Dec 31, 2024 |
1,815.00 |
| Sep 30, 2024 |
-3,366.00 |
| Jun 30, 2024 |
30.00 |
| Mar 31, 2024 |
-10,234.00 |
| Dec 31, 2023 |
-121.00 |
| Sep 30, 2023 |
2,033.00 |
| Jun 30, 2023 |
8,187.00 |
| Mar 31, 2023 |
-1,564.00 |
| Dec 31, 2022 |
-485.00 |
| Sep 30, 2022 |
6,132.00 |
| Jun 30, 2022 |
-1,838.00 |
| Mar 31, 2022 |
-4,681.00 |
| Dec 31, 2021 |
-705.00 |
| Sep 30, 2021 |
-128.00 |
| Jun 30, 2021 |
-771.00 |
| Mar 31, 2021 |
-471.00 |
| Dec 31, 2020 |
-1,129.00 |
| Sep 30, 2020 |
-4,383.00 |
| Jun 30, 2020 |
-11,543.00 |
| Mar 31, 2020 |
-1,950.00 |
| Dec 31, 2019 |
-2,122.00 |
| Sep 30, 2019 |
-8,380.00 |
| Jun 30, 2019 |
-1,418.00 |
| Mar 31, 2019 |
-1,326.00 |
| Dec 31, 2018 |
-4,639.00 |
| Sep 30, 2018 |
-1,836.00 |
| Jun 30, 2018 |
-2,992.00 |
| Mar 31, 2018 |
-2,903.00 |
| Dec 31, 2017 |
-2,210.00 |
| Sep 30, 2017 |
58.00 |
| Jun 30, 2017 |
-827.00 |
| Mar 31, 2017 |
-339.00 |
| Dec 31, 2016 |
1,789.00 |
| Sep 30, 2016 |
1,822.00 |
| Jun 30, 2016 |
1,770.00 |
| Mar 31, 2016 |
2,063.00 |
| Dec 31, 2015 |
2,442.00 |
| Sep 30, 2015 |
2,677.00 |
| Jun 30, 2015 |
2,654.00 |
| Mar 31, 2015 |
3,969.00 |
| Dec 31, 2014 |
2,062.00 |
| Sep 30, 2014 |
984.00 |
| Jun 30, 2014 |
1,992.00 |
| Mar 31, 2014 |
1,358.00 |
| Dec 31, 2013 |
-434.00 |
| Sep 30, 2013 |
-1,080.00 |
| Jun 30, 2013 |
-1,266.00 |
| Mar 31, 2013 |
-1,847.00 |
| Dec 31, 2012 |
-1,262.00 |
| Sep 30, 2012 |
-1,028.00 |
| Jun 30, 2012 |
-555.00 |
| Mar 31, 2012 |
-2,269.00 |
